| 51 |
23186954 | Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report. | 2013 Jan-Feb |
1 |
| 52 |
23717787 | Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction. | 2013 Jun |
1 |
| 53 |
23719553 | Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. | 2013 Jul |
1 |
| 54 |
23919123 | A Novel Approach for High Level Expression of Soluble Recombinant Human Parathyroid Hormone (rhPTH 1-34) in Escherichia coli. | 2013 Jul |
2 |
| 55 |
25019031 | Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. | 2013 Dec |
3 |
| 56 |
21874319 | A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism. | 2012 Apr |
4 |
| 57 |
21932115 | Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. | 2012 Jun |
3 |
| 58 |
22406438 | Vitamin D compounds and diabetic nephropathy. | 2012 Jul 1 |
1 |
| 59 |
22863242 | Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism? | 2012 Aug 3 |
2 |
| 60 |
23208191 | Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients. | 2012 |
1 |
| 61 |
21273999 | Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity. | 2011 Aug |
1 |
| 62 |
21449769 | Primary hyperparathyroidism as the first clinical manifestation of multiple endocrine neoplasia type 2A in a 5-year-old child. | 2011 May |
2 |
| 63 |
21960229 | [Diagnosis and treatment of urolithiasis with primary hyperparathyroidism]. | 2011 Oct |
1 |
| 64 |
19230880 | Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. | 2010 Mar 1 |
1 |
| 65 |
19781123 | Low calcium:phosphorus ratio in habitual diets affects serum parathyroid hormone concentration and calcium metabolism in healthy women with adequate calcium intake. | 2010 Feb |
1 |
| 66 |
20059333 | Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. | 2010 |
1 |
| 67 |
20649764 | Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism. | 2010 Aug 1 |
1 |
| 68 |
20731105 | [Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease]. | 2010 |
1 |
| 69 |
20811335 | The bone and mineral disorder of children undergoing chronic peritoneal dialysis. | 2010 Dec |
2 |
| 70 |
20852376 | Effect of high-flux versus low-flux dialysis membranes on parathyroid hormone. | 2010 Oct |
1 |
| 71 |
20936886 | Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy. | 2010 |
1 |
| 72 |
21034990 | Vitamin D and the skin. | 2010 Nov-Dec |
1 |
| 73 |
19216809 | Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women. | 2009 Oct |
1 |
| 74 |
19290408 | [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience]. | 2009 |
1 |
| 75 |
19365139 | Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet. | 2009 |
1 |
| 76 |
19396314 | [The role of calcium, calcitriol and their receptors in parathyroid regulation]. | 2009 |
2 |
| 77 |
18238737 | Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. | 2008 Jan-Feb |
1 |
| 78 |
18309349 | Is parathyroid hormone measurement useful for the diagnosis of renal bone disease? | 2008 Mar |
1 |
| 79 |
18998031 | [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience]. | 2008 Sep-Oct |
1 |
| 80 |
19032923 | The skeleton: endocrine regulator of phosphate homeostasis. | 2008 Dec |
2 |
| 81 |
25983953 | A new paradigm for the treatment of secondary hyperparathyroidism. | 2008 Jan |
1 |
| 82 |
17111159 | Growth and PTH in prepubertal children on long-term dialysis. | 2007 Sep |
1 |
| 83 |
17471006 | [Guideline for the management of chronic kidney disease-related mineral and bone disorders (CKD-MBD)]. | 2007 May |
1 |
| 84 |
17654321 | Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study. | 2007 |
1 |
| 85 |
17942777 | Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism. | 2007 Nov |
2 |
| 86 |
17976086 | Attainment of the Japanese Society for Dialysis Therapy guidelines for the management of secondary hyperparathyroidism in chronic hemodialysis patients in our clinic. | 2007 Oct |
1 |
| 87 |
16441824 | Looking at calcimimetics impact on hypercalcemia of immobilization: hypotheses and a case study. | 2006 Jan |
1 |
| 88 |
16568023 | Primary hyperparathyroidism related to a parathyroid adenoma: the dramatic clinical evolution of a misdiagnosed patient and its surgical solution. | 2006 Feb |
1 |
| 89 |
16868704 | Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease? | 2006 |
2 |
| 90 |
16925861 | High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. | 2006 Sep |
1 |
| 91 |
17117292 | Hypoparathyroidism and pseudohypoparathyroidism. | 2006 Aug |
1 |
| 92 |
15354199 | Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients. | 2005 Jan |
1 |
| 93 |
15785941 | Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. | 2005 May |
1 |
| 94 |
17373206 | [What are the actual indications for a surgical parathiroidectomy?]. | 2005 Dec |
1 |
| 95 |
15283317 | [Impact of a quality program in hemodialysis]. | 2004 |
2 |
| 96 |
15461740 | K/DOQI guidelines for bone metabolism and disease in chronic kidney disease patients: some therapeutic implications. | 2004 Sep-Oct |
1 |
| 97 |
15577030 | [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients]. | 2004 May |
1 |
| 98 |
15595334 | Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. | 2004 Dec |
1 |
| 99 |
15663548 | Dose-response study of 22-oxacalcitriol in patients with secondary hyperparathyroidism. | 2004 Dec |
1 |
| 100 |
12612963 | New strategies for the treatment of secondary hyperparathyroidism. | 2003 Mar |
1 |